NTI is pleased to announce the appointment of Nathan A. Paxton as a senior director on NTI’s Global Biological Policy and Programs team (NTI | bio). In this role, he will work to reduce global catastrophic biological risks, with a focus on shaping state intentions by disincentivizing the development and use of bioweapons. Nathan will also contribute to NTI | bio efforts to drive progress in bolstering global health security.
“Nathan comes to NTI with extensive experience working on global health security as a congressional staffer and as an academic, and he is an impressive strategic thinker,” said NTI | bio Vice President Jaime Yassif. “We’re excited to have him on board.”
Prior to joining NTI, Paxton served as a legislative assistant to U.S. Senator Angus S. King, Jr. (I-ME), where he worked as the senator’s principal policy advisor on global health and health security; international development and assistance; and voting rights, democracy, and campaign finance. Paxton has also held several academic positions including as a Professorial Lecturer at American University’s School of International Service, an adjunct professor in the Georgetown University Graduate School of Arts and Sciences and as a lecturer at Harvard University.
In addition to his work in Congress and academic appointments, Paxton has consulted for the “aids2031” project of the Social Science Research Council and for UNAIDS.
Paxton received his Ph.D. in Political Science from Harvard University. He earned master’s degrees from the University of California—Berkeley (M.A., Political Science) and Cambridge University (MPhil, International Relations). Paxton received his bachelor’s degree from the University of California, Davis.
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI | bio and the Center for International Security and Strategy (CISS) at Tsinghua University convened a virtual dialogue on risks at the convergence of artificial intelligence and the life sciences (AIxBio).
New YouGov polling commissioned by NTI and ReThink Media finds that nearly 80 percent of registered voters, across party lines, say it is in the interest of U.S. national security to work with China to mitigate catastrophic threats associated with nuclear risks, AI development, and bioterrorism.
NTI | bio and Concordia AI, with technical input from SecureBio, have launched the AIxBio Technical Working Group on Evaluation Practice. Convened through the AIxBio Global Forum, the Working Group will bring together experts from organizations in China, the European Union, the United Kingdom, and the United States that develop or conduct biological capability evaluations of AI systems.
Sign up for regular updates on innovative, real-world solutions to existential threats.
